Trademark: 88567311
Status Date
Monday, October 25, 2021
Filing Date
Monday, August 5, 2019
Published for Opposition
Tuesday, January 26, 2021
Abandoned Date
Monday, October 25, 2021
5 Medical diagnostic tests comprised of assays that test for the presence of medical biomarkers present in human body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays that test for the presence of medical biomarkers present in human body fluids by applying machine learning technology for use in detecting endometriosis
9 Downloadable software in the nature of a mobile application for use in entering, monitoring, tracking, recording, sharing and exporting information, test results and data related to diagnosing endometriosis
10 Medical diagnostic testing equipment incorporating sterile medical specimen collection tools in the nature of swabs, saliva collection tubes, and collection cards for the collection of saliva for use in testing for endometriosis by analyzing saliva, sold as a unit with instructions and return shipping packaging
42 Providing medical testing services and information in the field of endometriosis for medical research purposes; Providing scientific analysis and informational reports based upon results of laboratory testing in the field of endometriosis; Scientific research in the field of endometriosis; Providing online computer databases featuring medical research information in the field of endometriosis; Computer services, namely, hosting and maintaining an online portal for others to access and share information, test results and data in the field of endometriosis; Providing temporary use of non-downloadable software for use in creating, displaying, sharing and storing information, test results and data in the field of endometriosis
44 Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Consulting services in the fields of diagnostic medical testing; Providing medical information, consultancy and advisory services; Providing medical testing services and information in the field of endometriosis for diagnostic or treatment purposes; Medical testing services, namely, diagnostic testing services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic or treatment purposes; Providing online computer databases featuring information in the field of endometriosis for diagnostic or treatment purposes
"DOT PROGESTERONE RESISTANCE"
Oct 25, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 25, 2021
Abandonment - No Use Statement Filed
Mar 23, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 26, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2021
Published For Opposition
Jan 12, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 12, 2021
Teas Change Of Correspondence Received
Jan 12, 2021
Teas Change Of Owner Address Received
Jan 6, 2021
Notification Of Notice Of Publication E-Mailed
Dec 21, 2020
Approved For Pub - Principal Register
Dec 14, 2020
Examiner's Amendment Entered
Dec 14, 2020
Notification Of Examiners Amendment E-Mailed
Dec 14, 2020
Examiners Amendment E-Mailed
Dec 14, 2020
Examiners Amendment -Written
Sep 29, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 29, 2020
Teas Change Of Correspondence Received
Sep 29, 2020
Teas Change Of Owner Address Received
Jun 15, 2020
Notification Of Final Refusal Emailed
Jun 15, 2020
Final Refusal E-Mailed
Jun 15, 2020
Final Refusal Written
Jun 2, 2020
Teas/Email Correspondence Entered
Jun 2, 2020
Correspondence Received In Law Office
May 22, 2020
Assigned To Lie
May 18, 2020
Teas Response To Office Action Received
Nov 19, 2019
Notification Of Non-Final Action E-Mailed
Nov 19, 2019
Non-Final Action E-Mailed
Nov 19, 2019
Non-Final Action Written
Nov 4, 2019
Assigned To Examiner
Aug 22, 2019
New Application Office Supplied Data Entered In Tram
Aug 8, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
